Plans to allow pharmacists to save the NHS money by overruling doctors’ prescriptions for branded medicines have been delayed after concerns about patient safety and compliance.

Months after the Department of Health was expected to announce detailed guidelines, it is poised instead to launch a formal consultation triggered by criticism from doctors, patients and companies.